MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Registry for Study of Coils in Intracranial Aneurysms

Completed

Conditions: Cerebral Aneurysms

First Posted Date: 2009-10-23

Last Posted Date: 2019-06-06

Lead Sponsor: Mayo Clinic

Target Recruit Count: 114

Registration Number: NCT01000675

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Venlafaxine and Hypnosis or Focused Attention in Treating Patients with Hot Flashes

Not Applicable

Completed

Conditions: Hot Flashes

Interventions: Drug: placebo
Drug: venlafaxine
Procedure: mind-body intervention procedure
Procedure: hypnotherapy

First Posted Date: 2009-10-23

Last Posted Date: 2025-01-08

Lead Sponsor: Mayo Clinic

Target Recruit Count: 71

Registration Number: NCT01000623

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer

Phase 3

Terminated

Conditions: Recurrent Breast Carcinoma
Neuropathy
Pain
Stage IV Breast Cancer

Interventions: Drug: Calcium Gluconate
Other: Placebo
Drug: Magnesium Sulfate
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Drug: Ixabepilone

First Posted Date: 2009-10-20

Last Posted Date: 2016-02-04

Lead Sponsor: Mayo Clinic

Target Recruit Count: 1

Registration Number: NCT00998738

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant

Phase 2

Completed

Conditions: Stage II Multiple Myeloma
Stage III Multiple Myeloma
Multiple Myeloma
Stage I Multiple Myeloma
Refractory Multiple Myeloma

Interventions: Drug: plerixafor
Drug: filgrastim

First Posted Date: 2009-10-20

Last Posted Date: 2015-05-14

Lead Sponsor: Mayo Clinic

Target Recruit Count: 40

Registration Number: NCT00998049

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids.

Phase 4

Completed

Conditions: Symptomatic Uterine Leiomyomas
Myomas
Uterine Fibroids
Fibroids

Interventions: Procedure: Uterine artery embolization (UAE)
Procedure: Focused ultrasound (MRgFUS)

First Posted Date: 2009-10-15

Last Posted Date: 2018-01-12

Lead Sponsor: Mayo Clinic

Target Recruit Count: 56

Registration Number: NCT00995878

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Duke University Health System, Durham, North Carolina, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma

Phase 1

Withdrawn

Conditions: Multiple Myeloma
Refractory Multiple Myeloma

Interventions: Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation
Procedure: allogeneic bone marrow transplantation
Drug: bortezomib
Drug: melphalan
Drug: anti-thymocyte globulin
Drug: sirolimus
Drug: tacrolimus
Radiation: total-body irradiation

First Posted Date: 2009-10-14

Last Posted Date: 2023-01-05

Lead Sponsor: Mayo Clinic

Registration Number: NCT00995059

Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration

Phase 1

Completed

Conditions: Prostate Cancer

First Posted Date: 2009-09-30

Last Posted Date: 2016-01-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 8

Registration Number: NCT00987376

Locations: 🇺🇸
Mayo Clinic Rochester, Rochester, Minnesota, United States

Photodynamic Therapy (PDT) in Lung Cancer

Not Applicable

Completed

Conditions: Lung Cancer

Interventions: Procedure: PHOTODYNAMIC THERAPY (PDT)

First Posted Date: 2009-09-25

Last Posted Date: 2012-11-15

Lead Sponsor: Mayo Clinic

Target Recruit Count: 35

Registration Number: NCT00984243

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Evaluation of Radiculitis Following Use of Bone Morphogenetic Protein-2 for Interbody Arthrodesis in Spinal Surgery

Completed

Conditions: Lumbar Degenerative Disease

First Posted Date: 2009-09-25

Last Posted Date: 2022-04-15

Lead Sponsor: Mayo Clinic

Target Recruit Count: 103

Registration Number: NCT00984672

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

The Effects of Decreasing the Lasix Dose on the Cardiorenal System

Phase 1

Completed

Conditions: Heart Failure
Kidney Dysfunction

Interventions: Drug: Furosemide

First Posted Date: 2009-09-23

Last Posted Date: 2015-07-20

Lead Sponsor: Mayo Clinic

Target Recruit Count: 41

Registration Number: NCT00982423

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy